Research ArticleCancer

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

See allHide authors and affiliations

Science Translational Medicine  19 Jul 2017:
Vol. 9, Issue 399, eaaa0984
DOI: 10.1126/scitranslmed.aaa0984
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article